Ziyadeh was appointed CEO of Julphar in February 2023. It distributes products to 50 countries across five continents, employs 2,300 people, and has 12 facilities in the Middle East and Africa. It produces about a million boxes of medicine per day. The company reported $441.7 million in revenues in 2022 and had $649 million in assets as of December 2022. Ziyadeh has over 25 years of experience in leadership roles in pharmaceuticals. Before Julphar, he was the CEO of Tabuk Pharmaceuticals and has previously held senior roles at Hikma Pharmaceuticals.